Edulis Therapeutics
Plug and Play · Founded by an Ex-NASA engineer and two gastroenterologists, Edulis is building the first drug delivery system for sustained, localized treatment of chronic GI diseases like IBD and colorectal cancer.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 Kyo DiagnosticsShared: colorectal cancer, drug, treatmentNot statedOther | Other | Not stated | Plug and Play |
 Eugit TherapeuticsShared: inflammatory bowel, bowel disease, drugActiveOther | Other | Active | YCS22 |
 Sixfold BioscienceShared: drug delivery, delivery system, therapeuticActiveOther | Other | Active | YCW18 |
 Intact TherapeuticsShared: drug delivery, gastrointestinal, treatmentActiveOther | Other | Active | YCW19 |
 Avro Life ScienceShared: drug deliveryActiveOther | Other | Active | YCW18 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 AidyShared: inflammatory bowel, bowel disease, chronicActiveAI | AI | Active | YCW24 |
 MedirShared: drug delivery, treatmentNot statedOther | Other | Not stated | 500 Global2021 |
 HHC MedicalShared: drug delivery, developing, healthNot statedOther | Other | Not stated | Antler2025 |
 Harmonic DiscoveryShared: disease such, cancer, drugActiveAI | AI | Active | YCS21 |
 SynsoryBioShared: disease such, cancer, drugActiveOther | Other | Active | YCW24 |
Also from Plug and Play
All of Plug and Play
Programs
| Program | Cohort | Source |
|---|---|---|
 Plug and Play | Not stated | Plug and Play Page |
About Edulis Therapeutics
Edulis Therapeutics is a health-focused company developing an innovative endoscopic implant system designed for sustained, localized drug delivery in chronic gastrointestinal diseases such as inflammatory bowel disease and colorectal cancer. The implant is administered during routine endoscopy and provides maintenance-free therapy for extended periods without the need for retrieval. By delivering high concentrations of medication directly to diseased tissue while minimizing systemic exposure, Edulis aims to enhance the therapeutic effectiveness of existing drugs and enable the localized use of treatments that are otherwise limited by systemic toxicity, poor tissue penetration, or gastric intolerance. This pioneering approach has the potential to transform treatment paradigms for chronic GI conditions by improving patient outcomes and reducing side effects.
- Category
- Other
- Location
- United States
- Checked
- 2h ago
Edulis Therapeutics: questions
Which accelerators did Edulis Therapeutics go through?
Edulis Therapeutics is listed by Plug and Play.
Where is Edulis Therapeutics based?
Edulis Therapeutics lists United States as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.